Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means the agency’s own highest classification or reported deaths or serious injuries, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
B. Braun Medical Inc. is recalling Cefoxitin and Dextrose injectable products due to visible particulate matter found in reserve sample units.
John W Hollis Inc is recalling 3 vials of Polidocanol 3% Solution due to the presence of particulate matter. The product was distributed in Missouri, Tennessee, Mississippi, and Wisconsin.
B. Braun Medical Inc. is recalling ProcalAmine injectable products due to visible particulate matter found in reserve samples.
B. Braun Medical Inc. is recalling 6.9% FreAmine HBC (Amino Acid Injection) units due to visible particulate matter found in reserve samples.
B. Braun Medical Inc. is recalling Cefepime Hydrochloride and Dextrose injection units because visible particulate matter was found in reserve samples.
Hospira Inc. is recalling Lidocaine Hydrochloride Injection due to confirmed particulate matter in the glass containers.
B. Braun Medical Inc. is recalling 0.9% Sodium Chloride Injection USP due to visible particulate matter found in reserve samples.
B. Braun Medical Inc. is recalling Hyperlyte CR injectable products because visible particulate matter was found in reserve sample units.
B. Braun Medical Inc. is recalling specific lots of Cefazolin Sodium injectable products because visible particulate matter was found in reserve sample units.
B. Braun Medical Inc. is recalling 15% Amino Acids Injection products due to visible particulate matter found in reserve sample units.
AbbVie is recalling 36 kits of Lupron Depot 45 mg due to a potentially defective needle stick protection device.
Caraco Pharmaceutical Laboratories is recalling 47,813 bottles of Children's Cetirizine Hydrochloride Chewable Tablets because they failed impurity testing for N-Oxide.
Caraco Pharmaceutical Laboratories is recalling 160,105 bottles of Venlafaxine Hydrochloride Extended-Release Tablets, 150 mg, because stability results showed the product did not meet drug release dissolution specifications.
Baxter Healthcare Corp. is recalling 211,752 bottles of 0.9% Sodium Chloride Irrigation, USP, 1000 mL, due to the presence of nylon fibers.
Teva Pharmaceuticals USA is recalling 72,356 bottles of Fluoxetine Capsules, 10 mg, due to a customer complaint trend regarding capsule odor.
Piramal Critical Care is recalling 12,600 bottles of Sevoflurane inhalation anesthetic because the product was too acidic, failing pH specifications.
AbbVie is recalling 12 kits of Lupron Depot-Ped due to a potentially defective needle stick protection device.
AbbVie is recalling 2,915 Lupron Depot kits because the syringe needle protection device may be defective. The recall covers nationwide distribution and Puerto Rico.
John W Hollis Inc is recalling 7 vials of Phosphatidylcholine Solution for Injection because the expiration date on the label is earlier than the date listed on the vial.
AbbVie is recalling 7,362 Lupron Depot kits because some may contain a syringe with a defective needle stick protection device.
Caraco Pharmaceutical Laboratories is recalling 91,777 bottles of Venlafaxine Hydrochloride Extended-Release Tablets, 37.5 mg, because stability results showed the product did not meet drug release dissolution specifications.
Teva Pharmaceuticals is recalling Fluoxetine Capsules due to a customer complaint trend regarding capsule odor, indicating chemical contamination.
Legacy Pharmaceutical Packaging is recalling 667,068 bottles of Fluoxetine Capsules, 20 mg, due to supplier complaints of unusual odor.
P&L Developments is recalling 1,363,338 bottles of Children's Triacting Night Time Cold & Cough with PE because small amounts of diphenhydramine and mannitol precipitated out of solution.
AbbVie is recalling 1,530 Lupron Depot kits because some may contain a syringe with a defective needle stick protection device.